BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25909175)

  • 1. Clinical evaluation of red cell distribution width and contrast-induced acute kidney injury in percutaneous coronary interventions.
    Nichols EL; Brown JR
    Coron Artery Dis; 2015 Jun; 26(4):283-5. PubMed ID: 25909175
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of red cell distribution width to contrast-induced acute kidney injury in patients undergoing a primary percutaneous coronary intervention.
    Akin F; Celik O; Altun I; Ayca B; Ozturk D; Satilmis S; Ayaz A; Tasbulak O
    Coron Artery Dis; 2015 Jun; 26(4):289-95. PubMed ID: 25714066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Zhao K; Li Y; Gao Q
    Int J Cardiol; 2015 Oct; 197():276-8. PubMed ID: 26142973
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?
    Silvain J; Collet JP; Montalescot G
    Eur Heart J; 2014 Jun; 35(23):1504-6. PubMed ID: 24722806
    [No Abstract]   [Full Text] [Related]  

  • 5. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
    Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-induced nephropathy in primary percutaneous coronary intervention.
    Gallagher S; Knight C
    Heart; 2011 Nov; 97(21):1723-5. PubMed ID: 21737582
    [No Abstract]   [Full Text] [Related]  

  • 7. Optical coherence tomography-guided percutaneous coronary intervention in a patient with chronic kidney disease using zero contrast administration.
    Rivero F; Antuña P; Cuesta J; García-Guimaraes M; Bastante T; Alfonso F
    Coron Artery Dis; 2019 Mar; 30(2):156-157. PubMed ID: 30531255
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced acute kidney injury in patients with non-ST-segment elevation myocardial infarction undergoing early versus delayed invasive strategy.
    Kocas B; Abaci O; Cetinkal G; Arslan S; Dalgic Y; Kocas C; Yildiz A; Ersanli M
    Int J Cardiol; 2016 Jan; 203():638-9. PubMed ID: 26580347
    [No Abstract]   [Full Text] [Related]  

  • 10. Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: a randomized controlled trial.
    Yamanaka T; Kawai Y; Miyoshi T; Mima T; Takagaki K; Tsukuda S; Kazatani Y; Nakamura K; Ito H
    Int J Cardiol; 2015 Jan; 178():136-41. PubMed ID: 25464237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet count and volume indices in patients with contrast-induced acute kidney injury and acute myocardial infarction treated invasively.
    Francuz P; Kowalczyk J; Swoboda R; Przybylska-Siedlecka K; Kozieł M; Podolecki T; Świątkowski A; Lenarczyk R; Średniawa B; Kalarus Z
    Kardiol Pol; 2015; 73(7):520-6. PubMed ID: 25761790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
    Akkoyun DÇ; Akyüz A; Kurt Ö; Bilir B; Alpsoy Ş; Güler N
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):613-20. PubMed ID: 26536986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast-induce acute kidney injury after percutaneous coronary intervention].
    Hase H; Kubo S
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():433-9. PubMed ID: 27534209
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk stratification of contrast-induced acute kidney injury after percutaneous coronary intervention: should we finally get rid of procedural variables?
    Andò G; Trio O; de Gregorio C
    Am J Cardiol; 2015 Jul; 116(2):337-8. PubMed ID: 25997371
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y; Maekawa Y; Miyata H; Inoue S; Ishikawa S; Sueyoshi K; Noma S; Kawamura A; Kohsaka S; Fukuda K
    J Am Coll Cardiol; 2013 Oct; 62(14):1260-1266. PubMed ID: 23770181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.